Overview
Announcements

Ordinary Adjustment | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 3rd December 2024

Solactive Global Genomics Immunology and Medical Revolution Index:

In the ordinary adjustment, the following composition will be implemented effective open 3rd December 2024:

CRISPR THERAPEUTICS AG
VERTEX PHARMACEUTICALS INC
BRISTOL-MYERS SQUIBB CO
INTELLIA THERAPEUTICS INC
ASTRAZENECA PLC
MERCK & CO. INC.
ABBVIE INC
ELI LILLY & CO
PFIZER INC
THERMO FISHER SCIENTIFIC INC
ROCHE HOLDING AG
NOVARTIS AG
JOHNSON & JOHNSON
BIONTECH SE
GENSCRIPT BIOTECH CORP
BEAM THERAPEUTICS INC
10X GENOMICS INC
SANOFI SA
LONZA GROUP AG
TWIST BIOSCIENCE CORP
LEGEND BIOTECH CORP
BIOGEN INC
ILLUMINA INC
QIAGEN NV
REGENERON PHARMACEUTICALS
MODERNA INC
NOVO NORDISK A/S
SK BIOPHARMACEUTICALS CO LTD
BIO-TECHNE CORP
GILEAD SCIENCES INC
IOVANCE BIOTHERAPEUTICS INC
SAMSUNG BIOLOGICS CO LTD
EXACT SCIENCES CORP
RECURSION PHARMACEUTICALS INC
GENMAB A/S
BRIDGEBIO PHARMA INC
EXELIXIS INC
SAREPTA THERAPEUTICS INC
NATERA INC
GUARDANT HEALTH INC
AMGEN INC
ULTRAGENYX PHARMACEUTICAL INC
TG THERAPEUTICS INC
AGILENT TECHNOLOGIES INC
PTC THERAPEUTICS INC
JAZZ PHARMACEUTICALS PLC
INCYTE CORP
INNOVENT BIOLOGICS INC
BECTON DICKINSON AND CO
VERACYTE INC